Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Yamada

Showing results (171-180 of 192) with videos related to

Pageof 20
Sort By:
Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology|February 18, 1998
Application of the polymerase chain reaction for the diagnosis of malignant lymphoma of the nasal and oral cavitiesK Mishima, H Matsuoka, E Yamada, et al.
Mutation Research|April 18, 2000
Cholesterol sulfate, an activator of protein kinase C mediating squamous cell differentiation: a reviewT Kuroki, T Ikuta, M Kashiwagi, et al.
Tissue Antigens|November 1, 1996
A new HLA-DQB1*0306 allele sharing motifs from DQB1*03032 and DQB1*04 sequencesS Saito, S Ota, K Hashizume, et al.
The American Journal of Pathology|February 10, 2000
Blockade of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularizationH Ozaki, M S Seo, K Ozaki, et al.
The American Journal of Pathology|September 11, 2001
Fibroblast growth factor-2 decreases hyperoxia-induced photoreceptor cell death in miceH Yamada, E Yamada, A Ando, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 16, 2012
A phase I dose-finding trial of recombinant interleukin-21 and rituximab in relapsed and refractory low grade B-cell lymphoproliferative disordersJohn M Timmerman, John C Byrd, David J Andorsky, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|June 20, 2018
Activity of Anti-CD19 Chimeric Antigen Receptor T Cells Against B Cell Lymphoma Is Enhanced by Antibody-Targeted Interferon-AlphaPatricia A Young, Reiko E Yamada, Kham R Trinh, et al.
The American Journal of Pathology|February 10, 2000
Platelet-derived growth factor-A-induced retinal gliosis protects against ischemic retinopathyH Yamada, E Yamada, A Ando, et al.
Molecular Cancer Therapeutics|January 28, 2022
89Zr-ImmunoPET Shows Therapeutic Efficacy of Anti-CD20-IFNα Fusion Protein in a Murine B-cell Lymphoma ModelKirstin A Zettlitz, Felix B Salazar, Reiko E Yamada, et al.
The American Journal of Pathology|June 11, 1999
Dramatic inhibition of retinal and choroidal neovascularization by oral administration of a kinase inhibitorM S Seo, N Kwak, H Ozaki, et al.
Pageof 20

Showing results (171-180 of 192) with videos related to

Sort By:
Pageof 20
Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology|February 18, 1998
Application of the polymerase chain reaction for the diagnosis of malignant lymphoma of the nasal and oral cavitiesK Mishima, H Matsuoka, E Yamada, et al.
Mutation Research|April 18, 2000
Cholesterol sulfate, an activator of protein kinase C mediating squamous cell differentiation: a reviewT Kuroki, T Ikuta, M Kashiwagi, et al.
Tissue Antigens|November 1, 1996
A new HLA-DQB1*0306 allele sharing motifs from DQB1*03032 and DQB1*04 sequencesS Saito, S Ota, K Hashizume, et al.
The American Journal of Pathology|February 10, 2000
Blockade of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularizationH Ozaki, M S Seo, K Ozaki, et al.
The American Journal of Pathology|September 11, 2001
Fibroblast growth factor-2 decreases hyperoxia-induced photoreceptor cell death in miceH Yamada, E Yamada, A Ando, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 16, 2012
A phase I dose-finding trial of recombinant interleukin-21 and rituximab in relapsed and refractory low grade B-cell lymphoproliferative disordersJohn M Timmerman, John C Byrd, David J Andorsky, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|June 20, 2018
Activity of Anti-CD19 Chimeric Antigen Receptor T Cells Against B Cell Lymphoma Is Enhanced by Antibody-Targeted Interferon-AlphaPatricia A Young, Reiko E Yamada, Kham R Trinh, et al.
The American Journal of Pathology|February 10, 2000
Platelet-derived growth factor-A-induced retinal gliosis protects against ischemic retinopathyH Yamada, E Yamada, A Ando, et al.
Molecular Cancer Therapeutics|January 28, 2022
89Zr-ImmunoPET Shows Therapeutic Efficacy of Anti-CD20-IFNα Fusion Protein in a Murine B-cell Lymphoma ModelKirstin A Zettlitz, Felix B Salazar, Reiko E Yamada, et al.
The American Journal of Pathology|June 11, 1999
Dramatic inhibition of retinal and choroidal neovascularization by oral administration of a kinase inhibitorM S Seo, N Kwak, H Ozaki, et al.
Pageof 20